- In April 2025, Precisionary Instruments, in collaboration with Agilent Technologies, launched a new initiative integrating its Compresstome vibrating microtome into Agilent’s Seahorse XF Flex tissue workflow. This enhancement advances live tissue metabolic analysis in research settings—highlighting the growing demand for integrated, automated sectioning systems for real-time physiological studies
- In March 2025, 10x Genomics released Visium HD, a groundbreaking spatial gene-expression platform. It enables single-cell-resolution transcriptome mapping on FFPE tissue sections, representing a major milestone in combining histological sectioning with spatial omics for precision diagnostics
- In May 2024, Bruker Corporation completed its acquisition of NanoString Technologies, significantly bolstering its spatial gene-expression and tissue sectioning capabilities. This strategic move consolidates Bruker’s position in advanced multi-omics tissue profiling
- In April 2023, LLS ROWIAK LaserLabSolutions GmbH unveiled the LaserMicrotome LM350, a laser-based tissue cutting system designed to deliver ultra-precise, artifact-minimized sections—ideal for delicate or high-resolution tissue applications
- In February 2025, Bruker Spatial Biology announced at AGBT 2025 the upcoming CosMx Human Whole Transcriptome Panel for spatial multiomics, shipping in April. The platform will allow simultaneous high-resolution profiling of RNA and proteins on the same tissue section, merging sectioning with multiplexed molecular analysis
